Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge

CL Hsieh, SR Leist, EH Miller, L Zhou… - Nature …, 2024 - nature.com
Abstract Ever-evolving SARS-CoV-2 variants of concern (VOCs) have diminished the
effectiveness of therapeutic antibodies and vaccines. Develo** a coronavirus vaccine that …

Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines

K Chen, L Zhang, Z Fang, J Li, C Li, W Song… - Frontiers in …, 2023 - frontiersin.org
By the end of 2022, different variants of Omicron had rapidly spread worldwide, causing a
significant impact on the Coronavirus disease 2019 (COVID-19) pandemic situation …

Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations

M Rosati, E Terpos, P Homan, C Bergamaschi… - Frontiers in …, 2023 - frontiersin.org
Introduction Cytokines and chemokines play an important role in sha** innate and
adaptive immunity in response to infection and vaccination. Systems serology identified …

Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management

E Terpos, AR Branagan, R García-Sanz… - Seminars in …, 2023 - Elsevier
Abstract Consensus Panel 5 (CP5) of the 11th International Workshop on Waldenstrom's
Macroglobulinemia (IWWM-11; held in October 2022) was tasked with reviewing the current …

[HTML][HTML] Immunogenicity of the Monovalent Omicron XBB. 1.5-Adapted BNT162b2 COVID-19 Vaccine in People Living with HIV (PLWH)

M Cherneha, I Zydek, P Braß, J Korth, S Jansen… - Vaccines, 2024 - mdpi.com
While SARS-CoV-2 has transitioned to an endemic phase, infections caused by newly
emerged variants continue to result in severe, and sometimes fatal, outcomes or lead to long …

The development of a rapid, high-throughput neutralization assay using a SARS-CoV-2 reporter

R Suzuki, A Kamiyama, H Ito, K Kawashiro… - Journal of Virological …, 2024 - Elsevier
Many methods have been developed to measure the neutralizing capacity of antibodies to
SARS-CoV-2. However, these methods are low throughput and can be difficult to quickly …

Diminished neutralizing activity against the XBB1. 5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus …

T Zhao, Y Tani, C Makino-Okamura, M Takita… - Frontiers in …, 2024 - frontiersin.org
This study investigates the neutralizing activity against the XBB1. 5 variant and the ancestral
strain in a population post-bivalent vaccination using a pseudo virus assay validated with …

[HTML][HTML] Longitudinal Analysis of Antibody Response Following SARS-CoV-2 Infection Depending on Disease Severity: A Prospective Cohort Study

C Zirou, S Gumeni, I Bellos, I Ntanasis-Stathopoulos… - Viruses, 2023 - mdpi.com
Objective: Severe coronavirus disease 19 (COVID-19) is characterized by a dysregulated
inflammatory response, with humoral immunity playing a central role in the disease course …

Targeting SIRT1 by Scopoletin to Inhibit XBB. 1.5 COVID-19 Life Cycle

M Sotoudeheian, SMS Mirahmadi… - Current Reviews in …, 2025 - benthamdirect.com
Natural products have historically driven pharmaceutical discovery, but their reliance has
diminished with synthetic drugs. Approximately 35% of medicines originate from natural …

Update on Bimervax® immunogenicity amplitude. Insights on humoral response against XBB. 1.5 from an extension study (NTC05142553)

C Borralleras, JC Sanz, P Arrazola… - Revista Española …, 2023 - pmc.ncbi.nlm.nih.gov
Rev Esp Quimioter 2023; 36 (6): 658-660 659 the capacity of PHH-1V booster immunization
to induce a broad humoral response against emerging variants, including the 2023 …